Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
21
SIGA Quote, Financials, Valuation and Earnings
Last price:
$5.25
Seasonality move
:
6.64%
Day range:
$5.10 - $5.25
52-week range:
$4.81 - $9.62
Dividend yield:
0%
P/E ratio:
16.41x
P/S ratio:
4.03x
P/B ratio:
1.92x
Volume:
872.4K
Avg. volume:
805.8K
1-year change:
-4.73%
Market cap:
$381.2M
Revenue:
$94.6M
EPS (TTM):
$0.32
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$283.1M | $0.07 | 16.03% | -30.17% | $31.85 |
|
ALDX
Aldeyra Therapeutics, Inc.
|
-- | -$0.12 | -- | -27.62% | $7.50 |
|
EBS
Emergent BioSolutions, Inc.
|
$160.5M | -$0.25 | -27.77% | -94.67% | $12.00 |
|
GOVX
GeoVax Labs, Inc.
|
-- | -- | -100% | -- | $270.83 |
|
SKYE
Skye Bioscience, Inc.
|
-- | -$0.33 | -- | -18.57% | $8.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$5.24 | -- | $381.2M | 16.41x | $0.60 | 0% | 4.03x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$22.20 | $31.85 | $3.8B | 9.65x | $0.00 | 0% | 3.49x |
|
ALDX
Aldeyra Therapeutics, Inc.
|
$1.66 | $7.50 | $99M | -- | $0.00 | 0% | -- |
|
EBS
Emergent BioSolutions, Inc.
|
$8.23 | $12.00 | $417.9M | 9.73x | $0.00 | 0% | 0.60x |
|
GOVX
GeoVax Labs, Inc.
|
$1.33 | $270.83 | $2.1M | -- | $0.00 | 0% | 1.27x |
|
SKYE
Skye Bioscience, Inc.
|
$0.70 | $8.25 | $24.2M | -- | $0.00 | 0% | 476.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
0.4% | 2.342 | 0.34% | 8.79x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
4.08% | 2.895 | 1.15% | 3.40x |
|
ALDX
Aldeyra Therapeutics, Inc.
|
25.98% | 7.724 | 4.98% | 2.52x |
|
EBS
Emergent BioSolutions, Inc.
|
52.76% | 1.956 | 90.64% | 2.22x |
|
GOVX
GeoVax Labs, Inc.
|
-- | 1.795 | -- | 2.75x |
|
SKYE
Skye Bioscience, Inc.
|
1.35% | 5.027 | 1.09% | 3.14x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$804.5K | -$9.5M | 11.1% | 11.15% | -250.38% | -$16.9M |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257.8M | $17.4M | 41.28% | 43.78% | 6.12% | -$52.7M |
|
ALDX
Aldeyra Therapeutics, Inc.
|
-$65.1K | -$6.7M | -46.89% | -59.72% | -- | -$5.3M |
|
EBS
Emergent BioSolutions, Inc.
|
$46.6M | -$16.6M | 4.42% | 9.83% | -11.16% | $73.8M |
|
GOVX
GeoVax Labs, Inc.
|
-$16.8K | -$6.4M | -433.69% | -433.69% | -635.8% | -$6.2M |
|
SKYE
Skye Bioscience, Inc.
|
-$180K | -$14.9M | -123.85% | -124.87% | -- | -$9.8M |
SIGA Technologies, Inc. vs. Competitors
-
Which has Higher Returns SIGA or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of -143.11% compared to SIGA Technologies, Inc.'s net margin of 96.33%. SIGA Technologies, Inc.'s return on equity of 11.15% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 43.78%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.21.2% -$0.08 $199.6M ACADACADIA Pharmaceuticals, Inc.90.77% $1.60 $1.3B -
What do Analysts Say About SIGA or ACAD?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.85 which suggests that it could grow by 43.47%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 ACADACADIA Pharmaceuticals, Inc.12 4 1 -
Is SIGA or ACAD More Risky?
SIGA Technologies, Inc. has a beta of 1.049, which suggesting that the stock is 4.923% more volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.833, suggesting its less volatile than the S&P 500 by 16.67%.
-
Which is a Better Dividend Stock SIGA or ACAD?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or ACAD?
SIGA Technologies, Inc. quarterly revenues are $3.8M, which are smaller than ACADIA Pharmaceuticals, Inc. quarterly revenues of $284M. SIGA Technologies, Inc.'s net income of -$5.4M is lower than ACADIA Pharmaceuticals, Inc.'s net income of $273.6M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 16.41x while ACADIA Pharmaceuticals, Inc.'s PE ratio is 9.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 4.03x versus 3.49x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.4.03x 16.41x $3.8M -$5.4M ACADACADIA Pharmaceuticals, Inc.3.49x 9.65x $284M $273.6M
-
Which has Higher Returns SIGA or ALDX?
Aldeyra Therapeutics, Inc. has a net margin of -143.11% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 11.15% beat Aldeyra Therapeutics, Inc.'s return on equity of -59.72%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.21.2% -$0.08 $199.6M ALDXAldeyra Therapeutics, Inc.-- -$0.11 $59.8M -
What do Analysts Say About SIGA or ALDX?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aldeyra Therapeutics, Inc. has an analysts' consensus of $7.50 which suggests that it could grow by 351.81%. Given that Aldeyra Therapeutics, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Aldeyra Therapeutics, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 ALDXAldeyra Therapeutics, Inc.3 1 0 -
Is SIGA or ALDX More Risky?
SIGA Technologies, Inc. has a beta of 1.049, which suggesting that the stock is 4.923% more volatile than S&P 500. In comparison Aldeyra Therapeutics, Inc. has a beta of 1.340, suggesting its more volatile than the S&P 500 by 34.008%.
-
Which is a Better Dividend Stock SIGA or ALDX?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Aldeyra Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Aldeyra Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or ALDX?
SIGA Technologies, Inc. quarterly revenues are $3.8M, which are larger than Aldeyra Therapeutics, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$5.4M is higher than Aldeyra Therapeutics, Inc.'s net income of -$6.5M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 16.41x while Aldeyra Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 4.03x versus -- for Aldeyra Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.4.03x 16.41x $3.8M -$5.4M ALDXAldeyra Therapeutics, Inc.-- -- -- -$6.5M
-
Which has Higher Returns SIGA or EBS?
Emergent BioSolutions, Inc. has a net margin of -143.11% compared to SIGA Technologies, Inc.'s net margin of -36.72%. SIGA Technologies, Inc.'s return on equity of 11.15% beat Emergent BioSolutions, Inc.'s return on equity of 9.83%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.21.2% -$0.08 $199.6M EBSEmergent BioSolutions, Inc.31.34% -$1.04 $1.1B -
What do Analysts Say About SIGA or EBS?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Emergent BioSolutions, Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 45.81%. Given that Emergent BioSolutions, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Emergent BioSolutions, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 EBSEmergent BioSolutions, Inc.2 0 0 -
Is SIGA or EBS More Risky?
SIGA Technologies, Inc. has a beta of 1.049, which suggesting that the stock is 4.923% more volatile than S&P 500. In comparison Emergent BioSolutions, Inc. has a beta of 2.354, suggesting its more volatile than the S&P 500 by 135.409%.
-
Which is a Better Dividend Stock SIGA or EBS?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Emergent BioSolutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Emergent BioSolutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or EBS?
SIGA Technologies, Inc. quarterly revenues are $3.8M, which are smaller than Emergent BioSolutions, Inc. quarterly revenues of $148.7M. SIGA Technologies, Inc.'s net income of -$5.4M is higher than Emergent BioSolutions, Inc.'s net income of -$54.6M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 16.41x while Emergent BioSolutions, Inc.'s PE ratio is 9.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 4.03x versus 0.60x for Emergent BioSolutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.4.03x 16.41x $3.8M -$5.4M EBSEmergent BioSolutions, Inc.0.60x 9.73x $148.7M -$54.6M
-
Which has Higher Returns SIGA or GOVX?
GeoVax Labs, Inc. has a net margin of -143.11% compared to SIGA Technologies, Inc.'s net margin of -630.04%. SIGA Technologies, Inc.'s return on equity of 11.15% beat GeoVax Labs, Inc.'s return on equity of -433.69%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.21.2% -$0.08 $199.6M GOVXGeoVax Labs, Inc.-- -$0.31 $4.9M -
What do Analysts Say About SIGA or GOVX?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand GeoVax Labs, Inc. has an analysts' consensus of $270.83 which suggests that it could grow by 20263.41%. Given that GeoVax Labs, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe GeoVax Labs, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 GOVXGeoVax Labs, Inc.3 1 0 -
Is SIGA or GOVX More Risky?
SIGA Technologies, Inc. has a beta of 1.049, which suggesting that the stock is 4.923% more volatile than S&P 500. In comparison GeoVax Labs, Inc. has a beta of 3.805, suggesting its more volatile than the S&P 500 by 280.533%.
-
Which is a Better Dividend Stock SIGA or GOVX?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. GeoVax Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. GeoVax Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or GOVX?
SIGA Technologies, Inc. quarterly revenues are $3.8M, which are larger than GeoVax Labs, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$5.4M is higher than GeoVax Labs, Inc.'s net income of -$6.3M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 16.41x while GeoVax Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 4.03x versus 1.27x for GeoVax Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.4.03x 16.41x $3.8M -$5.4M GOVXGeoVax Labs, Inc.1.27x -- -- -$6.3M
-
Which has Higher Returns SIGA or SKYE?
Skye Bioscience, Inc. has a net margin of -143.11% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 11.15% beat Skye Bioscience, Inc.'s return on equity of -124.87%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.21.2% -$0.08 $199.6M SKYESkye Bioscience, Inc.-- -$0.36 $20.3M -
What do Analysts Say About SIGA or SKYE?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Skye Bioscience, Inc. has an analysts' consensus of $8.25 which suggests that it could grow by 1081.95%. Given that Skye Bioscience, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Skye Bioscience, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 SKYESkye Bioscience, Inc.4 2 0 -
Is SIGA or SKYE More Risky?
SIGA Technologies, Inc. has a beta of 1.049, which suggesting that the stock is 4.923% more volatile than S&P 500. In comparison Skye Bioscience, Inc. has a beta of 2.866, suggesting its more volatile than the S&P 500 by 186.628%.
-
Which is a Better Dividend Stock SIGA or SKYE?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Skye Bioscience, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Skye Bioscience, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or SKYE?
SIGA Technologies, Inc. quarterly revenues are $3.8M, which are larger than Skye Bioscience, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$5.4M is higher than Skye Bioscience, Inc.'s net income of -$14.4M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 16.41x while Skye Bioscience, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 4.03x versus 476.49x for Skye Bioscience, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.4.03x 16.41x $3.8M -$5.4M SKYESkye Bioscience, Inc.476.49x -- -- -$14.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
